Form of Nonqualified Stock Option Agreement



 Exhibit 10.7 
 AVEO PHARMACEUTICALS, INC. 
 Nonqualified Stock Option
Agreement  
 Granted Under 2010 Stock Incentive Plan 
 1. Grant of Option. 
 This agreement evidences the grant by AVEO
Pharmaceuticals, Inc., a Delaware corporation (the “Company”), on             , 20[ ] (the “Grant Date”) to
[                    ], an [employee], [consultant], [director] of the Company (the “Participant”), of an option to purchase,
in whole or in part, on the terms provided herein and in the Company’s 2010 Stock Incentive Plan (the “Plan”), a total of
[                    ] shares (the “Shares”) of common stock, $.001 par value per share, of the Company (“Common
Stock”) at $[            ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on
[                ] (the “Final Exercise Date”). 
 It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations
promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under
its terms. 
 2. Vesting Schedule. 
 This option will become exercisable (“vest”) as to [                    ]. 

The right of exercise shall be cumulative so that to the extent the option is not exercised in any period to the maximum extent
permissible it shall continue to be exercisable, in whole or in part, with respect to all Shares for which it is vested until the earlier of the Final Exercise Date or the termination of this option under Section 3 hereof or the Plan.

 3. Exercise of Option. 
 (a) Form of Exercise. Each election to exercise this option shall be in writing (which may be in electronic form), in substantially the form of Notice of Stock Option Exercise attached hereto as
Exhibit A, signed by the Participant, and received by the Company at its principal office, accompanied by this agreement, and payment in full in the manner provided in the Plan, such manner to include payment by delivery of a notice of “net
exercise” to the Company. The Participant may purchase less than the number of shares covered hereby, provided that no partial exercise of this option may be for any fractional share. 







 (b) Continuous Relationship with the Company Required. Except as otherwise provided
in this Section 3, this option may not be exercised unless the Participant, at the time he or she exercises this option, is, and has been at all times since the Grant Date, an employee, officer or director of, or consultant or advisor to, the
Company or any other entity the employees, officers, directors, consultants, or advisors of which are eligible to receive option grants under the Plan (an “Eligible Participant”). 
 (c) Termination of Relationship with the Company. If the Participant ceases to be an Eligible Participant for any reason, then,
except as provided in paragraphs (d) and (e) below, the right to exercise this option shall terminate three months after such cessation (but in no event after the Final Exercise Date), provided that this option shall be
exercisable only to the extent that the Participant was entitled to exercise this option on the date of such cessation. Notwithstanding the foregoing, if the Participant, prior to the Final Exercise Date, violates the non-competition or
confidentiality provisions of any employment contract, confidentiality and nondisclosure agreement or other agreement between the Participant and the Company, the right to exercise this option shall terminate immediately upon such violation.

 (d) Exercise Period Upon Death or Disability. If the Participant dies or becomes disabled (within the meaning of
Section 22(e)(3) of the Code) prior to the Final Exercise Date while he or she is an Eligible Participant and the Company has not terminated such relationship for “cause” as specified in paragraph (e) below, this option shall be
exercisable, within the period of one year following the date of death or disability of the Participant, by the Participant (or in the case of death by an authorized transferee), provided that this option shall be exercisable only to
the extent that this option was exercisable by the Participant on the date of his or her death or disability, and further provided that this option shall not be exercisable after the Final Exercise Date. 
 (e) Termination for Cause. If, prior to the Final Exercise Date, the Participant’s employment or other relationship with the
Company is terminated by the Company for Cause (as defined below), the right to exercise this option shall terminate immediately upon the effective date of such termination of employment or other relationship. If, prior to the Final Exercise Date,
the Participant is given notice by the Company of the termination of his or her employment or other relationship by the Company for Cause, and the effective date of such employment or other termination is subsequent to the date of the delivery of
such notice, the right to exercise this option shall be suspended from the time of the delivery of such notice until the earlier of (i) such time as it is determined or otherwise agreed that the Participant’s employment or other
relationship shall not be terminated for Cause as provided in such notice or (ii) the effective date of such termination of employment or other relationship (in which case the right to exercise this option shall, pursuant to the preceding
sentence, terminate immediately upon the effective date of such termination of employment or other relationship). “Cause” shall mean conduct involving one or more of the following: (i) the conviction of the employee of, or, plea of
guilty or nolo contendere to, any crime involving dishonesty or any felony; (ii) the willful misconduct by the employee resulting in material harm to the Company; (iii) fraud, embezzlement, theft or dishonesty by the employee against the
Company resulting in material harm to the Company; (iv) the repeated and continuing failure of the employee to follow the proper and lawful directions of the Company’s Chief Executive Officer or the Board after a written demand is
delivered to the employee that specifically identifies the manner in which the Chief Executive Officer or the Board believes that the Employee has failed to follow such instructions; (v) the employee’s current alcohol or prescription drug
abuse affecting work performance, or current illegal use of drugs regardless

  

 -2- 








 
of the effect on work performance; (vi) material violation of the Company’s code of conduct by the employee that causes harm to the Company; or (vii) violation of any applicable
written proprietary information, confidentiality, non-competition and/or non-solicitation agreements with the Company. The Participant’s employment or other relationship shall be considered to have been terminated for “Cause” if the
Company determines, within 30 days after the Participant’s resignation, that termination for Cause was warranted. 
 4. Withholding.

 No Shares will be issued pursuant to the exercise of this option unless and until the Participant pays to the Company, or
makes provision satisfactory to the Company for payment of, any federal, state or local withholding taxes required by law to be withheld in respect of this option. 
 5. Nontransferability of Option. 
 This option may not be sold, assigned,
transferred, pledged or otherwise encumbered by the Participant, either voluntarily or by operation of law, except by will or the laws of descent and distribution, and, during the lifetime of the Participant, this option shall be exercisable only by
the Participant. 
 6. Provisions of the Plan. 
 This option is subject to the provisions of the Plan (including the provisions relating to amendments to the Plan), a copy of which is furnished to the Participant with this option. 
 IN WITNESS WHEREOF, the Company has caused this option to be executed under its corporate seal by its duly authorized officer. This option
shall take effect as a sealed instrument. 
  

					
	AVEO PHARMACEUTICALS, INC.
		
	By:	 	 
		 	Name:	 	 
		 	Title:	 	 


  

 -3- 








 PARTICIPANT’S ACCEPTANCE 
 The undersigned hereby accepts the foregoing option and agrees to the terms and conditions thereof. The undersigned hereby acknowledges
receipt of a copy of the Company’s 2010 Stock Incentive Plan. 
  

			
	PARTICIPANT:
	
	 
		
	Address:	 	 
		
		 	 


  

 -4- 








 Exhibit A 
 NOTICE OF STOCK OPTION EXERCISE 
 Date: ____________ 
 AVEO Pharmaceuticals, Inc. 
 75 Sidney Street

 Cambridge, MA 02139 
 Attention:
Treasurer 
 Dear Sir or Madam: 
 I am the holder of a Nonqualified Stock Option granted to me under the AVEO Pharmaceuticals, Inc. (the “Company”) 2010 Stock Incentive Plan on __________ for the purchase of __________ shares of
Common Stock of the Company at a purchase price of $__________ per share. 
 I hereby exercise my option to purchase _________
shares of Common Stock (the “Shares”), for which I have enclosed __________ in the amount of ________. Please register my stock certificate as follows: 
  

					
			
		 	Name(s):	 	 
			
		 		 	 
			
		 	Address:	 	 
			
		 	Tax I.D. #:	 	 

  

	
	Very truly yours,
	
	  
	(Signature)

  

 -5-